Ccx282-B, an orally active inhibitor of chemokine receptor Ccr9, shows anti-inflammatory and clinical activity in the treatment of Crohn's disease

Authors
Publication date
1 January 2007
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Supporting member

    Oxford University Research Archive

    redirect
    oaioai:ora.ox.ac.uk:uuid:37f13f4e...
    Last time updated on 30/09/2015

    Oxford University Research Archive (ORA)

    redirect
    Last time updated on 18/04/2020

    ORA - Oxford University Research Archive

    redirect
    oaioai:ora.ox.ac.uk:uuid:37f13f4e...
    Last time updated on 13/04/2022